| scholarly article | Q13442814 |
| P2093 | author name string | Luster AD | |
| Leder P | |||
| Greenberg SM | |||
| P2860 | cites work | The molecular biology of leukocyte chemoattractant receptors | Q40661169 |
| Fixed drug eruptions: evidence for a cytokine-mediated process. | Q41152185 | ||
| Betaglycan presents ligand to the TGF beta signaling receptor. | Q41542611 | ||
| Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4 | Q41600712 | ||
| A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. | Q41619287 | ||
| Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor | Q41665564 | ||
| Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells | Q41717630 | ||
| The kit ligand: A cell surface molecule altered in steel mutant fibroblasts | Q41718670 | ||
| A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells | Q41747818 | ||
| The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin | Q42209173 | ||
| A macrophage LPS-inducible early gene encodes the murine homologue of IP-10. | Q42633103 | ||
| Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity | Q42937062 | ||
| Interaction of platelet factor four with cultured vascular endothelial cells | Q43846978 | ||
| Platelet factor 4 inhibits human megakaryocytopoiesis in vitro | Q45287046 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ | Q59068529 | ||
| Introduction of stable high-copy-number DNA into Chinese hamster ovary cells by electroporation | Q67295556 | ||
| Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4 | Q67657724 | ||
| Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo | Q68423000 | ||
| Binding of platelet factor 4 to cultured human umbilical vein endothelial cells | Q71417814 | ||
| Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides | Q24298587 | ||
| Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins | Q24300179 | ||
| Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity | Q24612623 | ||
| High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR | Q27731247 | ||
| Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa | Q27861105 | ||
| Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis | Q28268096 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine | Q33780320 | ||
| Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan | Q34250105 | ||
| Animal cell mutants defective in heparan sulfate polymerization | Q35533573 | ||
| Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration | Q35755712 | ||
| Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer | Q36162332 | ||
| Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). | Q36353962 | ||
| Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques | Q36355271 | ||
| Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells | Q36361823 | ||
| Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors | Q36362227 | ||
| IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo | Q36362293 | ||
| Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. | Q36453167 | ||
| A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis | Q36891922 | ||
| Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation | Q37577496 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules | Q38345199 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 219-231 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation | |
| P478 | volume | 182 |
| Q35812102 | Accelerated wound healing phenotype in Interleukin 12/23 deficient mice |
| Q24303828 | An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 |
| Q34537757 | Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte |
| Q35048828 | Analysis of the role of chemokines in angiogenesis. |
| Q41874982 | Anginex, a designed peptide that inhibits angiogenesis |
| Q30428793 | Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. |
| Q34391833 | Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction |
| Q41113308 | Anti-CXCL4 monoclonal antibody accelerates telogen to anagen transition and attenuates apoptosis of the hair follicle in mice |
| Q37600224 | Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study |
| Q80020827 | Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay |
| Q41060711 | Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans |
| Q36438574 | CXC and CC chemokine receptors on coronary and brain endothelia |
| Q33698057 | CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3 |
| Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
| Q38456370 | CXCL14 enhances proliferation and migration of NCI-H460 human lung cancer cells overexpressing the glycoproteins containing heparan sulfate or sialic acid |
| Q36187349 | CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. |
| Q30433527 | CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages |
| Q44305003 | CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). |
| Q58064340 | CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells |
| Q39010600 | CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. |
| Q37827339 | CXCR3 ligands: redundant, collaborative and antagonistic functions |
| Q34206173 | CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance |
| Q38599089 | CXCR3 plays a critical role for host protection against Salmonellosis |
| Q38407325 | CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis |
| Q34096557 | CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses |
| Q24803773 | CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis |
| Q91713842 | Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte |
| Q39904117 | Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity |
| Q28205223 | Cell surface heparan sulfate participates in CXCL1-induced signaling |
| Q90248438 | Chemokine Receptors and Phagocyte Biology in Zebrafish |
| Q48315564 | Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. |
| Q37827607 | Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function |
| Q43792050 | Chemokine receptor dimerization: two are better than one. |
| Q24336187 | Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes |
| Q34231598 | Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. |
| Q40845964 | Chemokine receptors and chemokines in HIV infection |
| Q37385515 | Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture |
| Q60931267 | Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization |
| Q93001507 | Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers |
| Q71092750 | Chemokines as inhibitors of hematopoietic progenitors |
| Q38018862 | Chemokines in CNS injury and repair |
| Q26778684 | Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring |
| Q86199528 | Chemokines in cancer |
| Q35395913 | Chinese herbal medicine for miscarriage affects decidual micro-environment and fetal growth. |
| Q40721527 | Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC. |
| Q40419683 | Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth. |
| Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
| Q38948540 | Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization |
| Q27641187 | Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine |
| Q45861749 | Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12. |
| Q41472342 | Cytokine regulation of endothelial cell function: from molecular level to the bedside |
| Q37148152 | Cytokines in cancer immunotherapy |
| Q24683742 | Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor |
| Q40639238 | Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity. |
| Q36513909 | Development of a novel chemokine-mediated in vivo T cell recruitment assay |
| Q48162018 | Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis. |
| Q73386834 | Differential expression of chemokines in normal pancreas and in chronic pancreatitis |
| Q24563090 | Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells |
| Q55131902 | Differential role of CXCR3 in inflammation and colorectal cancer. |
| Q35648177 | Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. |
| Q43211595 | Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells |
| Q41878742 | Downregulation of MMP2 and Bcl-2 in Adipose Derived Stem Cells (ASCs) following Transfection with IP-10 Gene |
| Q38106961 | Dual Role of CXCL10 as Conductor of Cellular Trafficking during Type 1 Diabetes |
| Q47688061 | Endothelial activation by cytokines |
| Q35753240 | Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions |
| Q74299680 | Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation |
| Q30494903 | Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney |
| Q41892162 | Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice |
| Q77701735 | Epidermal growth factor receptor-mediated motility in fibroblasts |
| Q37384020 | Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer |
| Q35792171 | Expression Analysis of the T-Cell-Targeting Chemokines CXCL9 and CXCL10 in Mice and Humans with Endothelial Infections Caused by Rickettsiae of the Spotted Fever Group |
| Q40778652 | Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells |
| Q43046782 | Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. |
| Q44555272 | Expression, purification, and characterization of Escherichia coli-derived recombinant human melanoma growth stimulating activity |
| Q41829509 | Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. |
| Q24322029 | Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells |
| Q38287875 | Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements |
| Q41307265 | Heparan sulfate in immune responses |
| Q34289445 | Heparanase enhances myeloma progression via CXCL10 downregulation |
| Q41186157 | Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q36401443 | Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor |
| Q53156977 | IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. |
| Q24305068 | IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain |
| Q36382107 | IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity |
| Q24311291 | Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion |
| Q49412994 | Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms |
| Q39517388 | Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent |
| Q73844814 | In vitro and in vivo systems to assess role of C-X-C chemokines in regulation of angiogenesis |
| Q42278450 | Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. |
| Q34769124 | Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer |
| Q51628940 | Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. |
| Q37356393 | Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice |
| Q40794919 | Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4 |
| Q77846780 | Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria |
| Q41886939 | Interferon gamma-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and Granulocyte/Macrophage colony-stimulating factor |
| Q36367319 | Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases |
| Q24647146 | Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 |
| Q30856401 | Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. |
| Q35931062 | Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q40847197 | Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10. |
| Q39016794 | Knock-down of CD44 regulates endothelial cell differentiation via NFκB-mediated chemokine production |
| Q33745172 | Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring |
| Q28259171 | Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4 |
| Q24321318 | Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2 |
| Q41560712 | Molecular mechanisms of blood vessel formation |
| Q58883554 | Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and IFN-γ in human neutrophils |
| Q28349180 | Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis |
| Q39426093 | Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells. |
| Q41657939 | New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road |
| Q41045856 | Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation. |
| Q49524220 | Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. |
| Q30874393 | Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5. |
| Q30332571 | Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. |
| Q38111715 | Physiological and pathological angiogenesis in the adult pulmonary circulation |
| Q44639015 | Platelet factor 4 (PF-4)–induced neutrophil adhesion is controlled by src-kinases, whereas PF-4–mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase |
| Q33375217 | Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications |
| Q37351046 | Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes |
| Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
| Q39604493 | Pleural fluid mononuclear cells (PFMCs) from tuberculous pleurisy can migrate in vitro in response to CXCL10. |
| Q32025835 | Potential implications of chemokines in reproductive function: an attractive idea |
| Q47719302 | Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection |
| Q37760881 | Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection |
| Q38989094 | Pseudorabies viral replication is inhibited by a novel target of miR-21. |
| Q24291028 | Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells |
| Q93388600 | Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents |
| Q90479612 | Regulation of Macrophage and Dendritic Cell Function by Chondroitin Sulfate in Innate to Antigen-Specific Adaptive Immunity |
| Q38221172 | Regulation of chemokine expression in the tumor microenvironment |
| Q56943378 | Regulation of endothelial cell function by pro- and anti-inflammatory cytokines |
| Q28237665 | Regulation of the immune response by the interaction of chemokines and proteases |
| Q43938053 | Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells |
| Q36369820 | Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3 |
| Q36578846 | Skin tissue repair: Matrix microenvironmental influences |
| Q37728270 | Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10. |
| Q40922429 | Systemic sclerosis. A vascular perspective |
| Q91973506 | Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation |
| Q59806770 | Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis |
| Q36377797 | Temporal phenotypic features distinguish polarized macrophages in vitro |
| Q36172008 | The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 |
| Q92879880 | The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment |
| Q28239606 | The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4 |
| Q37156706 | The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan |
| Q24291904 | The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells |
| Q52039719 | The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. |
| Q28504884 | The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract |
| Q47384264 | The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. |
| Q28261508 | The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily |
| Q34670832 | The leukocyte cytoskeleton in cell migration and immune interactions |
| Q41716944 | The molecular and cellular biology of the chemokines |
| Q27010051 | The multifaceted functions of CXCL10 in cardiovascular disease |
| Q28583578 | The novel chemokine mob-1: involvement in adult respiratory distress syndrome |
| Q24811681 | The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent |
| Q47772542 | The role of CXC chemokines in the regulation of angiogenesis in association with lung cancer |
| Q34385436 | The role of CXC chemokines in the regulation of tumor angiogenesis |
| Q37863514 | The role of chemokines and their receptors in angiogenesis |
| Q37655274 | The role of chemokines in severe malaria: more than meets the eye. |
| Q36454235 | Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats |
| Q47671475 | Tumor angiogenesis is regulated by CXC chemokines |
| Q35507024 | Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment. |
| Q42051381 | Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors |
| Q35748830 | Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy |
| Q38526464 | Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells. |
| Q33556162 | Tumour vascularization: sprouting angiogenesis and beyond |
| Q43694761 | Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry |
| Q38350708 | Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site |
| Q37040823 | Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10 |
| Q36256452 | Visualization of chemokine binding sites on human brain microvessels |
Search more.